2013 Q1 Form 10-Q Financial Statement

#000088616313000040 Filed on May 08, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2012 Q1
Revenue $11.65M $5.636M
YoY Change 106.72% 44.66%
Cost Of Revenue $663.0K $155.0K
YoY Change 327.74% -70.75%
Gross Profit $10.99M $5.481M
YoY Change 100.47% 62.64%
Gross Profit Margin 94.31% 97.25%
Selling, General & Admin $4.500M $3.420M
YoY Change 31.58% -0.87%
% of Gross Profit 40.95% 62.4%
Research & Development $2.465M $2.817M
YoY Change -12.5% 41.56%
% of Gross Profit 22.43% 51.4%
Depreciation & Amortization $670.0K $678.0K
YoY Change -1.18% 13.0%
% of Gross Profit 6.1% 12.37%
Operating Expenses $2.465M $2.817M
YoY Change -12.5% -43.66%
Operating Profit $3.932M -$839.0K
YoY Change -568.65% -48.53%
Interest Expense $912.0K $701.0K
YoY Change 30.1% -279.74%
% of Operating Profit 23.19%
Other Income/Expense, Net -$2.562M $66.00K
YoY Change -3981.82% -102.95%
Pretax Income $1.370M -$773.0K
YoY Change -277.23% -81.19%
Income Tax $66.00K -$35.00K
% Of Pretax Income 4.82%
Net Earnings $1.495M $1.133M
YoY Change 31.95% -88.23%
Net Earnings / Revenue 12.83% 20.1%
Basic Earnings Per Share $0.07
Diluted Earnings Per Share $0.07 $57.33K
COMMON SHARES
Basic Shares Outstanding 20.19M shares 19.71B shares
Diluted Shares Outstanding 20.28M shares 19.74B shares

Balance Sheet

Concept 2013 Q1 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.000M $11.30M
YoY Change -55.75% -31.52%
Cash & Equivalents $5.037M $9.777M
Short-Term Investments $1.500M
Other Short-Term Assets $986.0K $1.300M
YoY Change -24.15% 30.0%
Inventory $2.838M $1.300M
Prepaid Expenses $941.0K
Receivables $4.600M $2.000M
Other Receivables $4.300M $7.600M
Total Short-Term Assets $17.74M $23.50M
YoY Change -24.51% -24.92%
LONG-TERM ASSETS
Property, Plant & Equipment $758.0K $400.0K
YoY Change 89.5% -50.0%
Goodwill $12.24M
YoY Change
Intangibles $55.32M
YoY Change
Long-Term Investments
YoY Change
Other Assets $451.0K $1.900M
YoY Change -76.26% -40.63%
Total Long-Term Assets $80.62M $86.50M
YoY Change -6.79% -16.34%
TOTAL ASSETS
Total Short-Term Assets $17.74M $23.50M
Total Long-Term Assets $80.62M $86.50M
Total Assets $98.36M $110.0M
YoY Change -10.58% -18.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.522M $7.900M
YoY Change -30.1% -39.23%
Accrued Expenses $4.518M $4.100M
YoY Change 10.2% -65.55%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $1.500M
YoY Change -100.0% -70.0%
Long-Term Debt Due $16.20M $4.600M
YoY Change 252.17%
Total Short-Term Liabilities $33.02M $27.20M
YoY Change 21.39% -39.01%
LONG-TERM LIABILITIES
Long-Term Debt $10.60M $26.40M
YoY Change -59.85% 32.0%
Other Long-Term Liabilities $966.0K $35.50M
YoY Change -97.28% -33.4%
Total Long-Term Liabilities $966.0K $61.90M
YoY Change -98.44% -15.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $33.02M $27.20M
Total Long-Term Liabilities $966.0K $61.90M
Total Liabilities $67.77M $91.50M
YoY Change -25.94% -24.25%
SHAREHOLDERS EQUITY
Retained Earnings -$681.3M
YoY Change
Common Stock $21.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $42.28M $42.28M
YoY Change 0.0%
Treasury Stock Shares 1.118M shares
Shareholders Equity $30.60M $18.50M
YoY Change
Total Liabilities & Shareholders Equity $98.36M $110.0M
YoY Change -10.58% -18.34%

Cashflow Statement

Concept 2013 Q1 2012 Q1
OPERATING ACTIVITIES
Net Income $1.495M $1.133M
YoY Change 31.95% -88.23%
Depreciation, Depletion And Amortization $670.0K $678.0K
YoY Change -1.18% 13.0%
Cash From Operating Activities $2.078M -$369.0K
YoY Change -663.14% -141.0%
INVESTING ACTIVITIES
Capital Expenditures $37.00K $19.00K
YoY Change 94.74%
Acquisitions $4.300M
YoY Change
Other Investing Activities $0.00 $4.000M
YoY Change -100.0% -117.24%
Cash From Investing Activities -$34.00K $3.945M
YoY Change -100.86% -117.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $9.714M $8.500M
YoY Change 14.28%
Cash From Financing Activities -$9.388M -$840.0K
YoY Change 1017.62% -103.37%
NET CHANGE
Cash From Operating Activities $2.078M -$369.0K
Cash From Investing Activities -$34.00K $3.945M
Cash From Financing Activities -$9.388M -$840.0K
Net Change In Cash -$7.344M $2.736M
YoY Change -368.42% 5.23%
FREE CASH FLOW
Cash From Operating Activities $2.078M -$369.0K
Capital Expenditures $37.00K $19.00K
Free Cash Flow $2.041M -$388.0K
YoY Change -626.03% -143.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
26000 USD
CY2013Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
45000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5854000 USD
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
5522000 USD
CY2013Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4518000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4961000 USD
CY2013Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
403000 USD
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
199000 USD
CY2013Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5457000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4881000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
USD
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1166000 USD
CY2013Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
752952000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
751503000 USD
CY2012Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
709000 USD
CY2013Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
1124000 USD
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2012Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000 USD
CY2012Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000 USD
CY2012Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1500000 shares
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1200000 shares
CY2013Q1 us-gaap Assets
Assets
98363000 USD
CY2012Q4 us-gaap Assets
Assets
104260000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
23823000 USD
CY2013Q1 us-gaap Assets Current
AssetsCurrent
17740000 USD
CY2013Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2767000 USD
CY2012Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2767000 USD
CY2012Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2767000 USD
CY2013Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3933000 USD
CY2013Q1 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
USD
CY2012Q4 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
USD
CY2012Q4 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
USD
CY2013Q1 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
1166000 USD
CY2012Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High
BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh
513000 USD
CY2013Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High
BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh
-1841000 USD
CY2012Q1 us-gaap Business Exit Costs
BusinessExitCosts
87000 USD
CY2013Q1 us-gaap Business Exit Costs
BusinessExitCosts
89000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12381000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5037000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7041000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9777000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2736000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7344000 USD
CY2013Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2012Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-200000 USD
CY2013Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-642000 USD
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
33333333 shares
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
33333333 shares
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21342888 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21278606 shares
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21342888 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21278606 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
21000 USD
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
21000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2661000 USD
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1133000 USD
CY2013Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentrations of Credit Risk</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash equivalents and investments and accounts receivable.</font></div><div style="line-height:120%;text-align:left;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company invests its excess cash principally in United States government debt securities, investment grade corporate debt securities and certificates of deposit. The Company has established guidelines relative to diversification and maturities that maintain safety and liquidity. These guidelines are periodically reviewed and modified to take advantage of trends in yields and interest rates. The Company has not experienced any significant losses on its cash equivalents, short-term investments or restricted investments for the periods ending </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2012</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2012</font><font style="font-family:inherit;font-size:10pt;">, cash deposits held at financial institutions in excess of FDIC insured amounts of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$250,000</font><font style="font-family:inherit;font-size:10pt;"> were approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$4.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$11.9 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;"> customers was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">64%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">28%</font><font style="font-family:inherit;font-size:10pt;"> of total accounts receivable at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">. Accounts receivable from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;"> customers was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">53%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">35%</font><font style="font-family:inherit;font-size:10pt;"> of total accounts receivable at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2012</font><font style="font-family:inherit;font-size:10pt;">.&#160; </font></div><div style="line-height:120%;text-align:left;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company currently obtains Captisol from a sole-source supplier.&#160; If this supplier was not able to supply the requested amounts of Captisol, the Company would be unable to continue to derive revenues from the sale of Captisol until it obtained an alternative source, which might take a considerable length of time.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
CY2013Q1 us-gaap Contractual Obligation
ContractualObligation
18530000 USD
CY2012Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
155000 USD
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
663000 USD
CY2013Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
399000 USD
CY2012Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
334000 USD
CY2013Q1 us-gaap Deferred Revenue
DeferredRevenue
600000 USD
CY2012Q4 us-gaap Deferred Revenue
DeferredRevenue
800000 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
486000 USD
CY2013Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
556000 USD
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2369000 USD
CY2013Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2125000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
8000 USD
CY2013Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
8000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Gross Current
DeferredTaxLiabilitiesGrossCurrent
1581000 USD
CY2013Q1 us-gaap Deferred Tax Liabilities Gross Current
DeferredTaxLiabilitiesGrossCurrent
1581000 USD
CY2013Q1 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
791000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
725000 USD
CY2013Q1 us-gaap Depreciation
Depreciation
100000 USD
CY2012Q1 us-gaap Depreciation
Depreciation
100000 USD
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
670000 USD
CY2012Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
678000 USD
CY2012Q1 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
2048000 USD
CY2013Q1 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
191000 USD
CY2013Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
191000 USD
CY2012Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
1871000 USD
CY2012Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
177000 USD
CY2013Q1 us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
USD
CY2012Q1 us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
177000 USD
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.07
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.06
CY2013Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
915000 USD
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1807000 USD
CY2013Q1 us-gaap Fair Value Inputs Discount Rate
FairValueInputsDiscountRate
0.24
CY2012 us-gaap Fair Value Inputs Discount Rate
FairValueInputsDiscountRate
0.28
CY2013Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
853000 USD
CY2013Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
14765000 USD
CY2012Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
13960000 USD
CY2013Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
-2508000 USD
CY2013Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
25302000 USD
CY2012Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
23647000 USD
CY2013Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P20Y
CY2013Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5186000 USD
CY2013Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-66000 USD
CY2013Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-174000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4593000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2400000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2400000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2400000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2400000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2400000 USD
CY2012Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
17000 USD
CY2013Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
USD
CY2012Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3416000 USD
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4502000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
12238000 USD
CY2013Q1 us-gaap Goodwill
Goodwill
12238000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-738000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1304000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1370000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-773000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.04
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0.06
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
1871000 USD
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
191000 USD
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.01
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.10
CY2013Q1 us-gaap Income Tax Expense Benefit Continuing Operations
IncomeTaxExpenseBenefitContinuingOperations
66000 USD
CY2012Q1 us-gaap Income Tax Expense Benefit Continuing Operations
IncomeTaxExpenseBenefitContinuingOperations
-35000 USD
CY2012Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
17000 USD
CY2013Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2098000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3506000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
33000 USD
CY2012Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
35000 USD
CY2012Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-609000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4118000 USD
CY2012Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
85000 USD
CY2013Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
142000 USD
CY2012Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
44000 USD
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-102000 USD
CY2012Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-175000 USD
CY2013Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-66000 USD
CY2013Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-120000 USD
CY2012Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
USD
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
157000 USD
CY2012Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
462000 USD
CY2012Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
29723 shares
CY2013Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
90652 shares
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
55912000 USD
CY2013Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
55319000 USD
CY2012Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
68150000 USD
CY2013Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
67557000 USD
CY2013Q1 us-gaap Interest Expense
InterestExpense
912000 USD
CY2012Q1 us-gaap Interest Expense
InterestExpense
701000 USD
CY2012Q1 us-gaap Interest Paid
InterestPaid
631000 USD
CY2013Q1 us-gaap Interest Paid
InterestPaid
991000 USD
CY2013Q1 us-gaap Inventory Net
InventoryNet
2838000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
1697000 USD
CY2012Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
100000 USD
CY2013Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
200000 USD
CY2013Q1 us-gaap Liabilities
Liabilities
67767000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
77775000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
104260000 USD
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
98363000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
35439000 USD
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
33017000 USD
CY2013Q1 us-gaap Line Of Credit Facility Periodic Payment
LineOfCreditFacilityPeriodicPayment
400000 USD
CY2012Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
13443000 USD
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2562000 USD
CY2012Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
66000 USD
CY2013Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
5494000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-840000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9388000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3945000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-34000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2078000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-369000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-169000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2720000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
1133000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
1495000 USD
CY2012Q4 us-gaap Notes Payable Current
NotesPayableCurrent
14835000 USD
CY2013Q1 us-gaap Notes Payable Current
NotesPayableCurrent
13212000 USD
CY2013Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2013Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
7719000 USD
CY2012Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
6475000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-839000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3932000 USD
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals
15547000 USD
CY2013Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1000000 USD
CY2013Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3200000 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2955000 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
829000 USD
CY2013Q1 us-gaap Other Assets Current
OtherAssetsCurrent
986000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
517000 USD
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
451000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1166000 USD
CY2012Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
USD
CY2013Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
966000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1086000 USD
CY2012Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
10000 USD
CY2013Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
13000 USD
CY2012Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
254000 USD
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
191000 USD
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19000 USD
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
37000 USD
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
801000 USD
CY2013Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
941000 USD
CY2013Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
USD
CY2012Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
8500000 USD
CY2013Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications </font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to the previously issued statement of operations for the three months ended March 31, 2012 for comparability purposes. This reclassification had no effect on the reported net income, stockholders' equity, and operating cash flows as previously reported.</font></div><div style="line-height:120%;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br clear="none"/></font></div></div>
CY2013Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
USD
CY2012Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
7500000 USD
CY2012Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
13000 USD
CY2013Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3000 USD
CY2012Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
160000 USD
CY2013Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
326000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5669000 USD
CY2013Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6215000 USD
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
758000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
788000 USD
CY2012Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
4589000 USD
CY2013Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
4622000 USD
CY2013Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
7000000 USD
CY2013Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
9714000 USD
CY2012Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
8500000 USD
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2817000 USD
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2465000 USD
CY2012Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
2767000 USD
CY2013Q1 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
3933000 USD
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-681263000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-682759000 USD
CY2013Q1 us-gaap Revenue Recognition Sales Returns
RevenueRecognitionSalesReturns
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Product Returns</font></div><div style="line-height:120%;padding-top:6px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the sale of the Avinza and Oncology product lines, the Company retained the obligation for returns of product that were shipped to wholesalers prior to the close of the transactions. The accruals for product returns, which were recorded as part of the accounting for the sales transactions, are based on historical experience. Any subsequent changes to the Company&#8217;s estimate of product returns are accounted for as a component of discontinued operations.</font></div></div>
CY2013Q1 us-gaap Revenue Recognition Services Royalty Fees
RevenueRecognitionServicesRoyaltyFees
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Sale of Royalty Rights</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company previously sold to third parties the rights to future royalties of certain of its products. As part of the underlying royalty agreements, the partners have the right to offset a portion of any future royalty payments owed to the Company to the extent of previous milestone payments. Accordingly, the Company deferred a portion of the revenue associated with each tranche of royalty right sold, equal to the pro-rata share of the potential royalty offset. Such amounts associated with the offset rights against future royalty payments will be recognized as revenue upon receipt of future royalties from the respective partners.</font></div></div>
CY2013Q1 us-gaap Revenues
Revenues
11651000 USD
CY2012Q1 us-gaap Revenues
Revenues
5636000 USD
CY2012Q1 us-gaap Royalty Revenue
RoyaltyRevenue
3060000 USD
CY2013Q1 us-gaap Royalty Revenue
RoyaltyRevenue
5826000 USD
CY2012Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
667000 USD
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1539000 USD
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
21635000 USD
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1911457 shares
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
709000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1124000 USD
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.70
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.68
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.011
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.011
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
848436 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.78
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
24123 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
39375 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
371750 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
11358000 USD
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
21635000 USD
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1911457 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1626606 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.99
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.90
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
15.99
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
13.96
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
30.63
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
19.13
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
21.92
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M29D
CY2012Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
10482000 USD
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y11M16D
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y1M10D
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M29D
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y1M10D
CY2013Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
302750 shares
CY2013Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
23401 shares
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
30596000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
26485000 USD
CY2012Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
8300000 USD
CY2011Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
112371 shares
CY2013Q1 us-gaap Tenant Reimbursements
TenantReimbursements
3200000 USD
CY2013Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1118222 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1118222 shares
CY2013Q1 us-gaap Treasury Stock Value
TreasuryStockValue
42280000 USD
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
42280000 USD
CY2013Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and liabilities, at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. The Company&#8217;s critical accounting policies are those that are both most important to the Company&#8217;s financial condition and results of operations and require the most difficult, subjective or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of the uncertainty of factors surrounding the estimates or judgments used in the preparation of the consolidated financial statements, actual results may materially vary from these estimates.</font></div></div>
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20280030 shares
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19738801 shares
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20189378 shares
CY2012Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19709078 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20189378 shares
CY2013Q1 lgnd Additional Percentage Of Contingent Consideration
AdditionalPercentageOfContingentConsideration
0.1
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19709078 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
90652 shares
CY2012Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
29723 shares
CY2013Q1 lgnd Amount Included In Current Portion Of Deferred Revenue
AmountIncludedInCurrentPortionOfDeferredRevenue
600000 USD
CY2013Q1 lgnd Amount Included In Long Term Portion Of Deferred Revenue
AmountIncludedInLongTermPortionOfDeferredRevenue
40000 USD
CY2013Q1 lgnd Advanced Manufacturing Payments
AdvancedManufacturingPayments
USD
CY2012Q4 lgnd Advanced Manufacturing Payments
AdvancedManufacturingPayments
2000 USD
CY2013Q1 lgnd Amount Of Revenue For Contingent Consideration
AmountOfRevenueForContingentConsideration
15000000 USD
CY2013Q1 lgnd Cash Deposits In Excess Of Fdic Insured Amount
CashDepositsInExcessOfFdicInsuredAmount
4400000 USD
CY2012Q4 lgnd Cash Deposits In Excess Of Fdic Insured Amount
CashDepositsInExcessOfFdicInsuredAmount
11900000 USD
CY2012Q4 lgnd Co Promote Termination Liability Current
CoPromoteTerminationLiabilityCurrent
4327000 USD
CY2013Q1 lgnd Co Promote Termination Liability Current
CoPromoteTerminationLiabilityCurrent
4257000 USD
CY2013Q1 lgnd Co Promote Termination Liability Noncurrent
CoPromoteTerminationLiabilityNoncurrent
7916000 USD
CY2012Q4 lgnd Co Promote Termination Liability Noncurrent
CoPromoteTerminationLiabilityNoncurrent
8207000 USD
CY2012Q4 lgnd Co Promote Termination Payments Receivable Current
CoPromoteTerminationPaymentsReceivableCurrent
4327000 USD
CY2013Q1 lgnd Co Promote Termination Payments Receivable Current
CoPromoteTerminationPaymentsReceivableCurrent
4257000 USD
CY2012Q4 lgnd Co Promote Termination Payments Receivable Noncurrent
CoPromoteTerminationPaymentsReceivableNoncurrent
8207000 USD
CY2013Q1 lgnd Co Promote Termination Payments Receivable Noncurrent
CoPromoteTerminationPaymentsReceivableNoncurrent
7916000 USD
CY2013Q1 lgnd Co Promotion Agreement Termination Assumed Payments Made By Assignee
CoPromotionAgreementTerminationAssumedPaymentsMadeByAssignee
853000 USD
CY2013Q1 lgnd Co Promotion Agreement Termination Fair Value Adjustments
CoPromotionAgreementTerminationFairValueAdjustments
-492000 USD
CY2012Q4 lgnd Co Promotion Agreement Termination Liability
CoPromotionAgreementTerminationLiability
12534000 USD
CY2013Q1 lgnd Co Promotion Agreement Termination Liability
CoPromotionAgreementTerminationLiability
12173000 USD
CY2013Q1 lgnd Co Promotion Agreement Termination Liability Current
CoPromotionAgreementTerminationLiabilityCurrent
4257000 USD
CY2013Q1 lgnd Co Promotion Agreement Termination Liability Noncurrent
CoPromotionAgreementTerminationLiabilityNoncurrent
7916000 USD
CY2013Q1 lgnd Collaborative Research And Development And Other Revenues
CollaborativeResearchAndDevelopmentAndOtherRevenues
4286000 USD
CY2012Q1 lgnd Collaborative Research And Development And Other Revenues
CollaborativeResearchAndDevelopmentAndOtherRevenues
1909000 USD
CY2013Q1 lgnd Current Portion Of Liability For Contingent Value Rights
CurrentPortionOfLiabilityForContingentValueRights
356000 USD
CY2012Q4 lgnd Current Portion Of Liability For Contingent Value Rights
CurrentPortionOfLiabilityForContingentValueRights
356000 USD
CY1996Q2 lgnd Date Of Settlement Agreement
DateOfSettlementAgreement
April 1996
CY2012Q4 lgnd Deposits Liabilities Noncurrent
DepositsLiabilitiesNoncurrent
538000 USD
CY2013Q1 lgnd Deposits Liabilities Noncurrent
DepositsLiabilitiesNoncurrent
567000 USD
CY1996Q2 lgnd Exchange Ratio Of Common Shares Related To Legal Settlement
ExchangeRatioOfCommonSharesRelatedToLegalSettlement
74.25
CY2013Q1 lgnd Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Fair Value Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetFairValueAdjustment
1658000 USD
CY2013Q1 lgnd Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Fair Value Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustment
-853000 USD
CY2013Q1 lgnd Finite Lived Intangible Assets Gross Including Goodwill
FiniteLivedIntangibleAssetsGrossIncludingGoodwill
47469000 USD
CY2012Q4 lgnd Finite Lived Intangible Assets Gross Including Goodwill
FiniteLivedIntangibleAssetsGrossIncludingGoodwill
47469000 USD
CY2013Q1 lgnd Lease Expiration Year Maximum
LeaseExpirationYearMaximum
2019
CY2013Q1 lgnd Lease Expiration Year Minimum
LeaseExpirationYearMinimum
2014
CY2013Q1 lgnd Liability For Contingent Value Rights
LiabilityForContingentValueRights
12384000 USD
CY2012Q4 lgnd Liability For Contingent Value Rights
LiabilityForContingentValueRights
10543000 USD
CY2013Q1 lgnd Limit Of Revenue For Contingent Consideration For Additional Percentage
LimitOfRevenueForContingentConsiderationForAdditionalPercentage
35000000 USD
CY2013Q1 lgnd Line Of Credit Facility Additional Payment On Borrowings Percentage
LineOfCreditFacilityAdditionalPaymentOnBorrowingsPercentage
0.06
CY2013Q1 lgnd Line Of Credit Facility Prepayment Amount
LineOfCreditFacilityPrepaymentAmount
100000 USD
CY2013Q1 lgnd Line Of Credit Facility Prepayment Fee Percentage
LineOfCreditFacilityPrepaymentFeePercentage
0.01
CY2013Q1 lgnd Long Term Portion Of Lease Exit Obligations
LongTermPortionOfLeaseExitObligations
5074000 USD
CY2012Q4 lgnd Long Term Portion Of Lease Exit Obligations
LongTermPortionOfLeaseExitObligations
5963000 USD
CY2013Q1 lgnd Maturity Period Of Highly Liquid Securities Maximum
MaturityPeriodOfHighlyLiquidSecuritiesMaximum
P3M
CY2013Q1 lgnd Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate Maximum
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRateMaximum
0.035
CY2013Q1 lgnd Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate Minimum
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRateMinimum
0.03
CY2013Q1 lgnd Maximum Period For Accounts Receivable Outstanding To Be Considered As Past Due
MaximumPeriodForAccountsReceivableOutstandingToBeConsideredAsPastDue
P90D
CY2013Q1 lgnd Minimum Period For Accounts Receivable Outstanding To Be Considered As Past Due
MinimumPeriodForAccountsReceivableOutstandingToBeConsideredAsPastDue
P30D
CY2013Q1 lgnd Non Cash Change In Estimated Fair Value Of Contingent Value Rights
NonCashChangeInEstimatedFairValueOfContingentValueRights
-1841000 USD
CY2012Q1 lgnd Non Cash Change In Estimated Fair Value Of Contingent Value Rights
NonCashChangeInEstimatedFairValueOfContingentValueRights
513000 USD
CY2013Q1 lgnd Non Restricted Equity And Debt Securities With Maturity Period
NonRestrictedEquityAndDebtSecuritiesWithMaturityPeriod
P3M
CY2011Q4 lgnd Number Of Compounds Covered In Settlement Agreement
NumberOfCompoundsCoveredInSettlementAgreement
2 compound
CY2013Q1 lgnd Operating Lease Adjustment For Accretion And Changes In Lease Assumptions
OperatingLeaseAdjustmentForAccretionAndChangesInLeaseAssumptions
100000 USD
CY2012Q4 lgnd Other Liabilities Other Immaterial Liabilities Not Separately Reported Noncurrent
OtherLiabilitiesOtherImmaterialLiabilitiesNotSeparatelyReportedNoncurrent
214000 USD
CY2013Q1 lgnd Other Liabilities Other Immaterial Liabilities Not Separately Reported Noncurrent
OtherLiabilitiesOtherImmaterialLiabilitiesNotSeparatelyReportedNoncurrent
USD
CY2013Q1 lgnd Payments To Contingent Value Right Holders
PaymentsToContingentValueRightHolders
USD
CY2012Q1 lgnd Payments To Contingent Value Right Holders
PaymentsToContingentValueRightHolders
4549000 USD
CY2013Q1 lgnd Percentage Of Contingent Consideration
PercentageOfContingentConsideration
0.2
CY2013Q1 lgnd Percentage Of Net Sales Payable As Royalty
PercentageOfNetSalesPayableAsRoyalty
0.065
CY2013Q1 lgnd Period Allowed For Return Of Products Maximum
PeriodAllowedForReturnOfProductsMaximum
P90D
CY2013Q1 lgnd Period Allowed For Return Of Products Minimum
PeriodAllowedForReturnOfProductsMinimum
P30D
CY2013Q1 lgnd Period For Which Available Resources Are Sufficient To Satisfy Anticipated Operating And Capital Requirements
PeriodForWhichAvailableResourcesAreSufficientToSatisfyAnticipatedOperatingAndCapitalRequirements
P12M
CY2011Q4 lgnd Registration Statement Form S3 Common Stock Issuance And Sale Authorized
RegistrationStatementFormS3CommonStockIssuanceAndSaleAuthorized
30000000 USD
CY2013Q1 lgnd Share Based Compensation Arrangement By Share Based Payment Award Fair Value Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueForfeitureRate
0.0984
CY2012Q1 lgnd Share Based Compensation Arrangement By Share Based Payment Award Fair Value Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueForfeitureRate
0.1118
CY2013Q1 lgnd Short Term Portion Of Lease Exit Obligations
ShortTermPortionOfLeaseExitObligations
3015000 USD
CY2012Q4 lgnd Short Term Portion Of Lease Exit Obligations
ShortTermPortionOfLeaseExitObligations
3039000 USD
CY2013Q1 lgnd Working Capital
WorkingCapital
-15300000 USD
CY2013Q1 dei Amendment Flag
AmendmentFlag
false
CY2013Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2013Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q1 dei Document Period End Date
DocumentPeriodEndDate
2013-03-31
CY2013Q1 dei Document Type
DocumentType
10-Q
CY2013Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000886163
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20234959 shares
CY2013Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2013Q1 dei Entity Registrant Name
EntityRegistrantName
LIGAND PHARMACEUTICALS INC

Files In Submission

Name View Source Status
0000886163-13-000040-index-headers.html Edgar Link pending
0000886163-13-000040-index.html Edgar Link pending
0000886163-13-000040.txt Edgar Link pending
0000886163-13-000040-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
lgnd-20130331.xml Edgar Link completed
lgnd-20130331.xsd Edgar Link pending
lgnd-20130331_cal.xml Edgar Link unprocessable
lgnd-20130331_def.xml Edgar Link unprocessable
lgnd-20130331_lab.xml Edgar Link unprocessable
lgnd-20130331_pre.xml Edgar Link unprocessable
lgnd-331201310q.htm Edgar Link pending
lgnd-ex311_3312013.htm Edgar Link pending
lgnd-ex312_3312013.htm Edgar Link pending
lgnd-ex321_3312013.htm Edgar Link pending
lgnd-ex322_3312013.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
spectrumlicenseagreement-e.htm Edgar Link pending
spectrumsupplyagreement-ex.htm Edgar Link pending